At 5.5% CAGR, the Europe Collagen Peptides Market is projected to be worth US$ 379.61 million by 2030, says The Business Market Insights

According to the Business Market Insights’ research, the Europe Collagen Peptides Market was valued at US$ 260.84 million in 2023 and is expected to reach US$ 379.61 million by 2030, registering a CAGR of 5.5% from 2023 to 2030. Wide application scope and strategic development initiatives by key market players are the critical factors attributed to the Europe collagen peptides market expansion.                    

Collagen peptide manufacturers across the world are investing significantly in strategic development initiatives such as product innovation, mergers & acquisitions, and expansion of their businesses to attract many consumers and enhance their market position. They increasingly invest in product innovation to expand their customer base and meet emerging consumer trends. For instance, in November 2022, Pawable, the UK-based manufacturer, launched "Collar-Gen," a powdered supplement to prevent joint, skin, and digestive issues in dogs. It contains five different types of 100% natural collagen peptides. Such product innovations help collagen peptides extend its reach and gain a competitive edge in international markets.

Various end-use industries are adopting business expansion strategies and scaling production capacity to provide better customer satisfaction. For instance, in July 2020, Rousselot and Giusto Faravelli announced a distribution partnership in Italy, effective from October 2020. Under this partnership, Faravelli distributes food and pharmaceutical gelatins, hydrolyzed collagens, and biomedical gelatins across Italy. Thus, expanding businesses to other regions or countries to cater to the increasing demand by consumers drives the market growth. Such development strategies by collagen peptide manufacturers extend their reach and gain a competitive edge in international markets.  

On the contrary, safety concerns and stringent regulations related to consumption of collagen peptides hurdles the growth of Europe collagen peptides market. 

Based on sources, the Europe collagen peptides market is segmented into bovine, porcine, poultry, marine, and others. The bovine segment held 33.8% share of Europe collagen peptides market in 2023, amassing US$ 88.24 million. It is projected to garner US$ 21.86 million by 2030 to expand at 4.7% CAGR during 2023–2030.

Based on form, the Europe collagen peptide market is segmented into dry and liquid. The dry segment held 75.7% share of Europe collagen peptides market in 2023, amassing US$ 197.38 million. It is projected to garner US$ 292.24 million by 2030 to expand at 5.8% CAGR during 2023–2030.

Based on application, the Europe collagen peptide market is segmented into food & beverages, pharmaceuticals & nutraceuticals, personal care, and others. The pharmaceuticals & nutraceuticals segment held 40.4% share of Europe collagen peptide market in 2023, amassing US$ 105.27 million. It is projected to garner US$ 148.96 million by 2030 to expand at 5.1 % CAGR during 2023–2030.  

Based on country, the Europe collagen peptide market has been categorized into Germany, France, Italy, the UK, Russia, and the rest of Europe. Our regional analysis states that the Rest of Europe captured 31.1% share of Europe collagen peptide market in 2023. It was assessed at US$ 81.22 million in 2023 and is likely to hit US$ 112.54 million by 2030, exhibiting a CAGR of 4.8% during the forecast period.      

Key players dominating the Europe collagen peptide market are BioCell Technology LLC; Ewald-Gelatine GmbH; GELITA AG; Lapi Gelatine SpA; Rousselot BV; Tessenderlo Group NV; and Weishardt Holding SA among others.   

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com